References
- Brown J. J., Duncan J. R., Heiken J. P., et al. Perfluoroctyl-bromide as a gastrointestinal contrast agent for MR imaging. Use with and without glucagon. Radiology 1991; 181: 455
- Chernisch S. M., Maglinte D. D. Glucagon. Common untoward reactions. Review and recommendations. Radiology 1990; 177: 145
- Goei R., Nix M., Kessels A. H., Ten Tusscher M. P. Use of antispasmodic drugs in double contrast barium enema examination. Glucagon or Buscopan?. Clin. Radiol. 1995; 50: 553
- James W. B., Melrose A. G. Metoclopramide in gastro-intestinal radiology. Clin. Radiol. 1969; 20: 57
- Kaminsky S., Laniado M., Gogoll M., et al. Gadopentetate dimeglumine as a bowel contrast agent. Safety and efficacy. Radiology 1991; 178: 503
- Lönnemark M., Hemmingsson A., Carlsten J., Ericsson A., Holtz E., Klaveness J. Superparamagnetic particles as an MRI contrast agent for the gastrointestinal tract. Acta Radiol. 1988; 29: 599
- Lönnemark M., Hemmingsson A., Bach-Gansmo T., et al. Effects of superparamagnetic particles as oral contrast medium at magnetic resonance imaging. A phase I clinical study. Acta Radiol. 1989; 30: 193
- Lönnemark M., Hemmingsson A., Bach-Gansmo T., et al. Superparamagnetic particles as oral contrast medium in magnetic resonance imaging of patients with malignant lymphoma. Acta. Radiol. 1991; 32: 232
- Marti-Bonmati L., Graells M., Ronchera-Oms C. L., Casillas C., Poyatos C. Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen. A comparative study of three drugs. Proc. Soc. Magn. Reson. 3rd Meeting. Berkeley 1995; 508
- Mattrey R. F., Trambert M. A., Brown J. J., et al. Perflubron as an oral contrast agent for MR imaging. Results of a phase III clinical trial. Radiology 1994; 191: 841
- Øksendal A. N., Bach-Gansmo T., Jacobsen T. F., Eide H., Andrew E. Oral magnetic particles. Results from clinical phase II trials in 216 patients. Acta Radiol. 1993; 34: 187
- Rijcken T. H. Pels, Davis M. A., Ros P. R. Intraluminal contrast agents for MR imaging of the abdomen and pelvis. J. Magn. Reson. Imaging 1994; 4: 291
- Reynolds J. E. Martindale, the extra pharmacopoeia30th edn. The Pharmaceutical Press, London 1993
- Rinck P. A., Smevik O., Nilsen G., et al. Oral magnetic particles in MR imaging of the abdomen and pelvis. Radiology 1991; 178: 775
- Rubin D. L., Muller H. H., Young S. W. Methods for the systematic investigation of gastrointestinal contrast media for MRI. Evaluation of intestinal distribution by radiographic monitoring. Magn. Reson. Imaging 1991; 9: 285
- Schnall M. D. Magnetic resonance of the hollow viscera. Textbook of gastrointestinal radiology, R. M. Gore, M. S. Levine, I. Laufer. W. B. Saunders, Philadelphia 1994; 114
- Thoeni R. F., Filson R. G. Abdominal and pelvic CT. Use of oral metoclopramide to enhance bowel opacification. Radiology 1988; 169: 391
- Thoeni R. F., Margulis A. R. The state of radiographic technique in the examination of the colon. A survey in 1987. Radiology 1988; 167: 1
- Van Beers B., Grandin C., Jamart J., Demeure R., Jacobsen T. F., Pringot J. Magnetic resonance imaging of lower abdominal and pelvic lesions. Assessment of oral magnetic particles as an intestinal contrast agent. Eur. J. Radiol. 1992; 14: 252